Attendee Person Persons

Hospital Ophir Loyola
no photo
Hospital Ophir Loyola
Concord Hospital Neurology
no photo
Concord Hospital
Neurology
Hospital Militar Campo de Mayo
no photo
Hospital Militar Campo de Mayo
IRCCS San Raffaele Scientific Institute Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience
no photo
IRCCS San Raffaele Scientific Institute
Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience
INERE
no photo
INERE
University of Connecticut, School of Engineering Physiology and Neurobiology
no photo
University of Connecticut, School of Engineering
Physiology and Neurobiology
University Hospital Basel and University of Basel Translational Imaging in Neurology (ThINk) Basel, Department of Medicine and Biomedical Engineering
no photo
University Hospital Basel and University of Basel
Translational Imaging in Neurology (ThINk) Basel, Department of Medicine and Biomedical Engineering
University Hospital Basel and University of Basel Translational Imaging in Neurology (ThINK) Basel, Department of Medicine and Biomedical Engineering
no photo
University Hospital Basel and University of Basel
Translational Imaging in Neurology (ThINK) Basel, Department of Medicine and Biomedical Engineering
Biogen
no photo
University of Campania “Luigi Vanvitelli” Department of Advanced Medical and Surgical Sciences
no photo
University of Campania “Luigi Vanvitelli”
Department of Advanced Medical and Surgical Sciences
University of California, San Francisco
no photo
University of California, San Francisco
Hacettepe University Faculty of Medicine Department of Neurology
no photo
Hacettepe University Faculty of Medicine
Department of Neurology
University of Verona Dept. of Neurosciences Biomedicine and Movements www.icare-ms.com
University of Verona
Dept. of Neurosciences Biomedicine and Movements
Massimiliano Calabrese is Professor of Neurology at Department of Neurosciences, Biomedicine and Movement at the University of Verona. He leads the Multiple Sclerosis Center of University of Verona and the International Centre for Advanced Research in Multiple Sclerosis (ICARE-MS). Following medical degree and training in neurology, he completed a clinical fellowship at the Neuroimmunology Branch of National Institute of Health in Bethesda. He has special expertise in advanced MRI acquisition and analysis particularly as they relate to understanding the pathogenesis and the evolution of Multiple Sclerosis. Since 2005 his clinical research activity has been focused on neurodegeneration and neuroprotection in Multiple Sclerosis, with the ultimate aim of predicting and of slowing down the accumulation and progression of irreversible disability. As a lead clinician in the MS service at Multiple Sclerosis Center of University Hospital of Verona, he has a strong commitment to patient care. Prof. Calabrese and his team follow more than 2.000 MS patients. He has contributed to the development of important pathways for new MS medications and developed international and local MRI protocols for diagnosing MS and monitoring patients on disease-modifying drugs. He runs specialist MS and diagnostic clinics with multidisciplinary input from therapists and MS specialist nurses. Over the last 15 years, Prof. Calabrese conducted more than 30 international Phase 2 and Phase 3 clinical trials in 12 of which he was the Principal Investigator He is currently the PI of 6 international Phase 2 and 3 Clinical Trials.
Johns Hopkins University Neurology and Neuroscience http://www.calabresilab.com/
Johns Hopkins University
Neurology and Neuroscience

Peter A. Calabresi, MD is a Professor of Neurology and Neuroscience at the Johns Hopkins School of Medicine and Director of the Johns Hopkins Multiple Sclerosis (MS) Center. Dr. Calabresi is also Director of the Richard T. Johnson Division of Neuroimmunology and Neuroinfectious Diseases. He earned his undergraduate degree from Yale College and medical degree from Brown University. Dr. Calabresi completed residency training at Strong Memorial Hospital in Rochester, NY, and completed a research fellowship at the National Institutes of Health, Neuroimmunology Branch. Dr. Calabresi serves on the Editorial Boards of the Journal of Clinical Investigation and the Multiple Sclerosis Journal. He served as Chair of a grant review committee of the National Multiple Sclerosis Society and was a standing member of the NIH Clinical Neuroimmunology and Brain Tumors Study Section. As co-director of the Johns Hopkins Precision Medicine MS Center of Excellence, Dr. Calabresi has been the principal investigator on several clinical trials and also oversees translational laboratory research projects. His specific laboratory research interest lies in understanding the mechanisms of T lymphocyte differentiation into effector memory T cells and how these T cells interface with glial cells in the brain to modulate remyelination. Dr. Calabresi has published over 300 research papers including numerous articles on imaging and the immunopathogenesis of MS. He was the recipient of a five-year NMSS Collaborative Center grant from the National MS Society to study endogenous remyelination in MS, and the Jacob Javits Neuroscience Investigator award from the National Institutes of Health. Dr. Calabresi was co-awarded the Barancik prize for innovation in MS research in 2015, and was elected to the American Association of Physicians in 2017.

University of Sydney Brain and Mind Centre
no photo
University of Sydney
Brain and Mind Centre
AOU San Luigi Gonzaga Pharmacy
no photo
AOU San Luigi Gonzaga
Pharmacy
Private Service
no photo
Private Service
Hospital das Clínicas – Faculdade de Medicina de São Paulo
no photo
Hospital das Clínicas – Faculdade de Medicina de São Paulo
Hospital Universitari Son Espases Department of Neurology
no photo
Hospital Universitari Son Espases
Department of Neurology
University College London Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences
no photo
University College London
Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences